The expression of USP5 was not related to gender, age, lymph node metastasis, pathological grade, the EGFR mutation and ALK translocation but was related to tumor size, and the difference was statistically significant. This evidence concerns the gene EGFR and metastatic malignant neoplasm in the lymph nodes.